Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: Implications for treatments

Ageing Research Reviews

Volumn 11, Issue 2, 2012, Pages 297-319

  Mocchegiani, Eugenio ^a   Costarelli, Laura ^a   Giacconi, Robertina ^a   Piacenza, Francesco ^a   Basso, Andrea ^a   Malavolta, Marco ^a  

^a INRCA   (Italy)

Author keywords

Ageing; Copper; Gene interaction; Iron; Metal speciation analysis; Zinc

Indexed keywords

1,10 PHENANTHROLINE; ASCORBIC ACID; CALCIUM; CLIOQUINOL; COBALAMIN; COPPER; DEFERIPRONE; DEFEROXAMINE; EDETIC ACID; FOLIC ACID; IRON; MACROPHAGE INFLAMMATORY PROTEIN; PHYTATE; REACTIVE OXYGEN METABOLITE; VITAMIN B COMPLEX; ZINC; ZINC FINGER PROTEIN;

AGILITY; AGING; ALOPECIA; ALZHEIMER DISEASE; ANEMIA; ANTIOXIDANT ACTIVITY; BONE DEVELOPMENT; CALCIUM BLOOD LEVEL; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHELATION THERAPY; COMORBIDITY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; FOOD INTAKE; GENE INTERACTION; GENE MUTATION; GENETIC VARIABILITY; HEMOCHROMATOSIS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; IRON BLOOD LEVEL; IRON CHELATION; IRON DEFICIENCY; IRON OVERLOAD; LONGEVITY; MALABSORPTION; MENKES SYNDROME; NEOPLASM; NEUTROPENIA; NONHUMAN; OXIDATIVE STRESS; PATIENT MOBILITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHLEBOTOMY; PREVALENCE; PROTEIN POLYMORPHISM; QUALITY OF LIFE; RETINA MACULA DEGENERATION; REVIEW; SPECIES DIFFERENTIATION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

AGE FACTORS; AGING; ANIMALS; CHELATING AGENTS; COPPER; DIETARY SUPPLEMENTS; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; INFLAMMATION; IRON; MICRONUTRIENTS; ZINC;

EID: 84857020239     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.01.004     Document Type: Review

References (278)

1. Adams, P.C., Reboussin, D.M., Press, R.D., Barton, J.C., Acton, R.T., Moses, G.C., Leiendecker-Foster, C., McLaren, G.D., Dawkins, F.W., Gordeuk, V.R., Lovato, L., Eckfeldt, J.H., 2007. Biological variability of transferrin saturation and unsaturated iron-binding capacity. Am. J. Med. 120, 999.e1-7.
2. Adlard P.A., Bica L., White A.R., Nurjono M., Filiz G., Crouch P.J., Donnelly P.S., Cappai R., Finkelstein D.I., Bush A.I. Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease. PLoS One 2011, 6:e17669.
3. Alberts M.J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A.M., Roses A.D. ApoE genotype and survival from intracerebral haemorrhage. Lancet 1995, 346:575.
4. Alvarez-León E.E., Román-Viñas B., Serra-Majem L. Dairy products and health: a review of the epidemiological evidence. Br. J. Nutr. 2006, 96:S94-S99.
5. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17589-17594.
6. Andrews G.K. Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals 2001, 14:223-237.
7. AREDS (Age-Related Eye Disease Study Research Group), 2001. A randomized, a placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119, 1417-1436.
8. Arizaga Rodríguez S., Blanco González E., Alvarez Llamas G., Montes-Bayón M., Sanz-Medel A. Detection of transferrin isoforms in human serum: comparison of UV and ICP-MS detection after CZE and HPLC separations. Anal. Bioanal. Chem. 2005, 383:390-397.
9. Bala S., Failla M.L. Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin 2 activity. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:794-797.
10. Bareggi, S.R., Cornelli, U., 2010. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. C.N.S. Neurosci. Ther. Dec 27. doi:10.1111/j.%201755-5949.2010.00231.
11. Barton J.C., Bottomley S.S. Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis. Am. J. Hematol. 2000, 65:223-226.
12. Bates D.L., Chen Y., Kim G., Guo L., Chen L. Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA. J. Mol. Biol. 2008, 381:1292-1306.
13. Bathum L., Christiansen L., Nybo H., Ranberg K.A., Gaist D., Jeune B., Petersen N.E., Vaupel J., Christensen K. Association of mutations in the hemochromatosis gene with shorter life expectancy. Arch. Intern. Med. 2001, 161:2441-2444.
14. Bayer T.A., Schafer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schussel K., Eikenberg O., Sturchler-Pierrat C., Abramowski D., Staufenbiel M., Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc. Assoc. Am. Physicians 2003, 100:14187-14192.
15. Bellamy, R., 1999. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect. 1, 23-27.
16. Blanchard R.K., Moore J.B., Green C.L., Cousins R.J. Modulation of intestinal gene expression by dietary zinc status: effectiveness of cDNA arrays for expression profiling of a single nutrient deficiency. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13507-13513.
17. Bolan C.D., Conry-Cantilena C., Mason G., Rouault T.A., Leitman S.F. MCV as a guide to phlebotomy therapy for hemochromatosis. Transfusion 2001, 41:819-827.
18. Bonham M., O'Connor J.M., Hannigan B.M., Strain J.J. The immune system as a physiological indicator of marginal copper status?. Br. J. Nutr. 2002, 87:393-403.
19. Bossy-Wetzel E., Talantova M.V., Lee W.D., Schölzke M.N., Harrop A., Mathews E., Götz T., Han J., Ellisman M.H., Perkins G.A., Lipton S.A. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004, 41:351-365.
20. Brewer G.J. Iron and copper toxicity in diseases of aging particularly atherosclerosis and Alzheimer's disease. Exp. Biol. Med. 2007, 232:323-335.
21. Brewer G.J. The risks of free copper in the body and the development of useful anticopper drugs. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:727-732.
22. Brewer G.J., Askari F., Dick R.B., Sitterly J., Fink J.K., Carlson M., Kluin K.J., Lorincz M.T. Treatment of Wilson's disease with tetrathiomolybdate V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Transl. Res. 2009, 154:70-77.
23. Brittenham G.M., Weiss G., Brissot P., Lainé F., Guillygomarc'h A., Guyader D., Moirand R., Deugnier Y. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hematol. Am. Soc. Hematol. Educ. Prog. 2000, 2000:39-50.
24. Bush A.I. Metals and neuroscience. Curr. Opin. Chem. Biol. 2000, 4:184-191.
25. Buttar N.S., DeMars C.J., Lomberk G., Rizvi S., Bonilla-Velez J., Achra S., Rashtak S., Wang K.K., Fernandez-Zapico M.E., Urrutia R. Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis. J. Biol. Chem. 2010, 285:11433-11444.
26. Cabreiro F., Perichon M., Jatje J., Malavolta M., Mocchegiani E., Friguet B., Petropoulos I. Zinc supplementation in the elderly subjects: effect on oxidized protein degradation and repair systems in peripheral blood lymphocytes. Exp. Gerontol. 2008, 43:483-487.
27. Candore G., Licastro F., Chiappelli M., Franceschi C., Lio D., Rita Balistreri C., Piazza G., Colonna-Romano G., Grimaldi L.M., Caruso C. Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy. Mech. Ageing Dev. 2003, 124:525-528.
28. Canela A., Vera E., Klatt P., Blasco M.A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5300-5305.
29. Canonne-Hergaux F., Gruenheid S., Ponka P., Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 1999, 93:4406-4417.
30. Caragounis A., Du T., Filiz G., Laughton K.M., Volitakis I., Sharples R.A., Cherny R.A., Masters C.L., Drew S.C., Hill A.F., Li Q.X., Crouch P.J., Barnham K.J., White A.R. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. Biochem. J. 2007, 407:435-450.
31. Carmel R. Anemia and aging: an overview of clinical diagnostic and biological issues. Blood Rev. 2001, 15:9-18.
32. Carru C., Pes G.M., Deiana L., Baggio G., Franceschi C., Lio D., Balistreri C.R., Candore G., Colonna-Romano G., Caruso C. Association between the HFE mutations and longevity: a study in Sardinian population. Mech. Ageing Dev. 2003, 124:529-532.
33. Casadei M., Persichini T., Polticelli F., Musci G., Colasanti M. S-glutathionylation of metallothioneins by nitrosative/oxidative stress. Exp. Gerontol. 2008, 43:415-422.
34. Cellier M.F., Courville P., Campion C. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect. 2007, 9:1662-1670.
35. Chen Y., Irie Y., Keung W.M., Maret W. S-nitrosothiols react preferentially with zinc thiolate clusters of metallothionein III through transnitrosation. Biochemistry 2002, 41:8360-8367.
36. Chernoff R. Nutrition and health promotion in older adults. J. Gerontol. A. Biol. Sci. Med. Sci. 2001, 56:47-53.
37. Cherny R.A., Legg J.T., McLean C.A., Fairlie D.P., Huang X., Atwood C.S., Beyreuther K., Tanzi R.E., Masters C.L., Bush A.I. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J. Biol. Chem. 1999, 274:23223-23228.
38. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y., Huang X., Goldstein L.E., Moir R.D., Lim J.T., Beyreuther K., Zheng H., Tanzi R.E., Masters C.L., Bush A.I. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 2001, 30:665-676.
39. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., Cardelli M., Monti D., Mariani E., Mocchegiani E. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 2006, 7:357-365.
40. Cook J.D., Dassenko S.A., Lynch S.R. Assessment of the role of nonheme-iron availability in iron balance. Am. J. Clin. Nutr. 1991, 54:717-722.
41. Coon K.D., Siegel A.M., Yee S.J., Dunckley T.L., Mueller C., Nagra R.M., Tourtellotte W.W., Reiman E.M., Papassotiropoulos A., Petersen F.F., Stephan D.A., Kirsch W.M. Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease. Alzheimers Dis. 2006, 9:225-233.
42. Cooper G.J., Phillips A.R., Choong S.Y., Leonard B.L., Crossman D.J., Brunton D.H., Saafi L., Dissanayake A.M., Cowan B.R., Young A.A., Occleshaw C.J., Chan Y.K., Leahy F.E., Keogh G.F., Gamble G.D., Allen G.R., Pope A.J., Boyd P.D., Poppitt S.D., Borg T.K., Doughty R.N., Baker J.R. Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004, 53:2501-2508.
43. Costarelli L., Muti E., Malavolta M., Giacconi R., Cipriano C., Sartini D., Emanuelli M., Silvestrini M., Provinciali L., Gobbi B., Mocchegiani E. Modulation of genes involved in zinc homeostasis in old low-grade atherosclerotic patients under effects of HMG-CoA reductase inhibitors. Rejuv. Res. 2008, 11:287-291.
44. Cousins R.J. Toward a molecular understanding of zinc metabolism. Clin. Physiol. Biochem. 1986, 4:20-30.
45. Cousins R.J. A role of zinc in the regulation of gene expression. Proc. Nutr. Soc. 1998, 57:307-311.
46. Cousins R.J. Gastrointestinal factors influencing zinc absorption and homeostasis. Int. J. Vit. Nutr. Res. 2010, 80:243-248.
47. Coyle P., Philcox J.C., Carey L.C., Rofe A.M. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 2002, 59:627-647.
48. Crapper McLachlan D.R., Dalton A.J., Kruck T.P., Bell M.Y., Smith W.L., Kalow W., Andrews D.F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 1991, 337:1304-1308.
49. Crichton R.R., Wilmet S., Legssyer R., Ward R.J. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 2002, 91:9-18.
50. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., Bush A.I. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J. Biol. Chem. 2000, 275:19439-19442.
51. Culotta V.C., Lin S.J., Schmidt P., Klomp L.W., Casareno R.L., Gitlin J. Intracellular pathways of copper trafficking in yeast and humans. Adv. Exp. Med. Biol. 1999, 448:247-254.
52. Danks D.M. Copper deficiency in humans. Annu. Rev. Nutr. 1988, 8:235-257.
53. Danzeisen R., Araya M., Harrison B., Keen C., Solioz M., Thiele D., McArdle H.J. How reliable and robust are current biomarkers for copper status? Br. J. Nutr. 2007, 98:76-83.
54. Das H., Kumar A., Lin Z., Patino W.D., Hwang P.M., Feinberg M.W., Majumder P.K., Jain M.K. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6653-6658.
55. del Castillo Busto M.E., Montes-Bayón M., Bettmer J., Sanz-Medel A. Stable isotope labelling and FPLC-ICP-SFMS for the accurate determination of clinical iron status parameters in human serum. Analyst 2008, 133:379-384.
56. Delmi M., Rapin C.H., Bengoa J.M., Delmas P.D., Vasey H., Bonjour J.P. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet 1990, 335:1013-1016.
57. Deloche C., Bastien P., Chadoutaud S., Galan P., Bertrais S., Hercberg S., de Lacharrière O. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur. J. Dermatol. 2007, 17:507-512.
58. Douabin-Gicquel V., Soriano N., Ferran H., Wojcik F., Palierne E., Tamim S., Jovelin T., McKie A.T., Le Gall J.Y., David V., Mosser J. Identification of 96 single nucleotide polymorphisms in eight genes involved in iron metabolism: efficiency of bioinformatic extraction compared with a systematic sequencing approach. Hum. Genet. 2001, 109:393-401.
59. Du X., She E., Gelbart T., Truksa J., Lee P., Xia Y., Khovananth K., Mudd S., Mann N., Moresco E.M., Beutler E., Beutler B. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008, 320:1088-1092.
60. Duffy S.J., Biegelsen E.S., Holbrook M., Russell J.D., Gokce N., Keaney J.F., Vita J.A. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001, 103:2799-2804.
61. Ekiz C., Agaoglu L., Karakas Z., Gurel N., Yalcin I. The effect of iron deficiency anemia on function of the immune system. Hematol. J. 2005, 5:579-583.
62. Eisenstaedt R., Penninx B.W., Woodman R.C. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006, 20:213-226.
63. El Balkhi S., Poupon J., Trocello J.M., Massicot F., Woimant F., Laprévote O. Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection. Anal. Chem. 2010, 82:6904-6910.
64. El Meskini R., Culotta V.C., Mains R.E., Eipper B.A. Supplying copper to the cuproenzyme peptidylglycine alpha-amidating monooxygenase. J. Biol. Chem. 2003, 278:12278-12284.
65. Erie J.C., Good J.A., Butz J.A., Pulido J.S. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration. Am. J. Ophthalmol. 2009, 147:276-282.
66. Erusalimsky J.D., Kurz D.J. Endothelial cell senescence. Handb. Exp. Pharmacol. 2006, 176:213-248.
67. Failla M.L. Trace elements and host defense: recent advances and continuing challenges. J. Nutr. 2003, 133:1443S-1447S.
68. Faux N.G., Ritchie C.W., Gunn A., Rembach A., Tsatsanis A., Bedo J., Harrison J., Lannfelt L., Blennow K., Zetterberg H., Ingelsson M., Masters C.L., Tanzi R.E., Cummings J.L., Herd C.M., Bush A.I. PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J. Alzheimers Dis. 2010, 20:509-516.
69. Fleming D.J., Jacques P.F., Dallal G.E., Tucker K.L., Wilson P.W., Wood R.J. Dietary determinants of iron stores in a free-living elderly population: The Framingham Heart Study. Am. J. Clin. Nutr. 1998, 67:722-733.
70. Fleming D.J., Tucker K.L., Jacques P.F., Dallal G.E., Wilson P.W., Wood R.J. Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am. J. Clin. Nutr. 2002, 76:1375-1384.
71. Ford E.S. Serum copper concentration and coronary heart disease among US adults. Am. J. Epidemiol. 2000, 151:1182-1188.
72. Fraker P.J., Lill-Elghanian D.A. The many roles of apoptosis in immunity as modified by aging and nutritional status. J. Nutr. Health Aging 2004, 8:56-63.
73. Franceschi C., Chiricolo M., Licastro F., Zannotti M., Masi M., Mocchegiani E., Fabris N. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects. J. Ment. Defic. Res. 1988, 32:169-181.
74. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured?. Nutr. Rev. 2007, 65:S173-S176.
75. Frederickson C.J., Burdette S.C., Frederickson C.J., Sensi S.L., Weiss J.H., Yin H.Z., Balaji R.V., Truong-Tran A.Q., Bedell E., Prough D.S., Lippard S.J. Method for identifying neuronal cells suffering zinc toxicity by use of a novel fluorescent sensor. J. Neurosci. Methods 2004, 139:79-89.
76. Freisinger P., Horvath R., Macmillan C., Peters J., Jaksch M. Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?. J. Inherit. Metab. Dis. 2004, 27:67-79.
77. Fukada T., Yamasaki S., Nishida K., Murakami M., Hirano T. Zinc homeostasis and signaling in health and diseases: zinc signaling. J. Biol. Inorg. Chem. 2011, 16:1123-1134.
78. Fukuyama S., Matsunaga Y., Zhanghui W., Noda N., Asai Y., Moriwaki A., Matsumoto T., Nakano T., Matsumoto K., Nakanishi Y., Inoue H. A zinc chelator TPEN attenuates airway hyperresponsiveness and airway inflammation in mice in vivo. Allergol. Int. 2011, 60:259-266.
79. Fülöp T., Larbi A., Dupuis G., Pawelec G. Ageing, autoimmunity and arthritis Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthr. Res. Ther. 2003, 5:290-302.
80. Garry P.J., Goodwin J.S., Hunt W.C. Iron status and anemia in the elderly: new findings and a review of previous studies. J. Am. Geriatr. Soc. 1983, 31:389-399.
81. Garry P.J., Montoya G.D., Baumgartner R.N., Liang H.C., Williams T.M., Brodie S.G. Impact of HLA-H mutations on iron stores in healthy elderly men and women. Blood Cells Mol. Dis. 1997, 23:277-287.
82. Garry P.J., Hunt W.C., Baumgartner R.N. Effects of iron intake on iron stores in elderly men and women: longitudinal and cross-sectional results. J. Am. Coll. Nutr. 2000, 19:262-269.
83. Giacconi R., Bonfigli A.R., Testa R., Sirolla C., Cipriano C., Marra M., Muti E., Malavolta M., Costarelli L., Piacenza F., Tesei S., Mocchegiani E. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol. Genet. Metab. 2008, 94:98-104.
84. Giacconi R., Muti E., Malavolta M., Cardelli M., Pierpaoli S., Cipriano C., Costarelli L., Tesei S., Saba V., Mocchegiani E. A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging. Rejuv. Res. 2008, 11:297-300.
85. Giacconi, R., Malavolta, M., Costarelli, L., Busco, F., Galeazzi, R., Bernardini, G., Gasparini, G., Mocchegiani, E., 2011. Comparison of intracellular zinc signals in non-adherent lymphocytes from young-adult and elderly donors: role of zinc transporters (Zip-family) and pro-inflammatory cytokines. J. Nutr. Biochem. doi:10.1016/j.nutbio.2011.07.005.
86. Gille G., Reichmann H. Iron-dependent functions of mitochondria--relation to neurodegeneration. J. Neural. Transm. 2011, 118:349-359.
87. González M., Reyes-Jara A., Suazo M., Jo W.J., Vulpe C. Expression of copper-related genes in response to copper load. Am. J. Clin. Nutr. 2008, 88:830S-834S.
88. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004, 104:2263-2268.
89. Guyatt G.H., Patterson C., Ali M., Singer J., Levine M., Turpie I., Meyer R. Diagnosis of iron-deficiency anemia in the elderly. Am. J. Med. 1990, 88:205-209.
90. Haase H., Ober-Blöbaum J.L., Engelhardt G., Hebel S., Heit A., Heine H., Rink L. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J. Immunol. 2008, 181:6491-6502.
91. Haase H., Rink L. The immune system and the impact of zinc during aging. Immun. Ageing 2009, 6:9-15.
92. Hainaut P., Mann K. Zinc binding and redox control of p53 structure and function. Antioxid. Redox Signal. 2001, 3:611-623.
93. Hallberg L. The pool concept in food iron absorption and some of its implications. Proc. Nutr. Soc. 1974, 33:285-291.
94. Hallberg L., Brune M., Rossander L. Effect of ascorbic acid on iron absorption from different types of meals. Hum. Nutr. Appl. Nutr. 1986, 40A:97-113.
95. Hallberg L., Hulten L., Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? Am. J. Clin. Nutr. 1997, 66:347-356.
96. Hallberg L., Rossander-Hulten L., Brune M., Gleerup A. Calcium and iron absorption: mechanism of action and nutritional importance. Eur. J. Clin. Nutr. 1992, 46:317-327.
97. Hamza I., Faisst A., Prohaska J., Chen J., Gruss P., Gitlin J.D. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6848-6852.
98. Hartmann H.J., Felix K., Nagel W., Weser U. Intestinal administration of copper and its transient release into venous rat blood serum concomitantly with metallothionein. Biometals 1993, 6:115-118.
99. Harvey L.J., Ashton K., Hooper L., Casgrain A., Fairweather-Tait S.J. Methods of assessment of copper status in humans: a systematic review. Am. J. Clin. Nutr. 2009, 89:2009S-2024S.
100. Hasegawa T., Wakita Y., Zhu Y., Matsuura H., Haraguchi H., Umemura T. Speciation of Human Serum Proteins Based on Trace Metal Mapping Analysis by CIM Monolithic Disk Column HPLC/ICP-MS in Complement with Off-Line MALDI-TOF-MS Analysis. Bull. Chem. Soc. Jpn. 2007, 80:503-550.
101. Hashemi M., Ghavami S., Eshraghi M., Booy E.P., Los M. Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. Eur. J. Pharmacol. 2007, 557:9-19.
102. Hayashi H., Wakusawa S., Motonishi S., Miyamoto K., Okada H., Inagaki Y., Ikeda T. Genetic background of primary iron overload syndromes in Japan. Intern. Med. 2006, 45:1107-1111.
103. Hazell T., Ledward D., Neale R. Iron availability from meat. Br. J. Nutr. 1978, 39:631-638.
104. Hentze M.W., Kühn L.C. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:8175-8182.
105. Hentze M.W., Caughman S.W., Casey J.L., Koeller D.M., Rouault T.A., Harford J.B., Klausner R.D. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. A model for the structure and functions of iron-responsive elements. Gene 1988, 72:201-208.
106. Hopkins R.G., Failla M.L. Copper deficiency reduces interleukin-2 (IL-2) production and IL-2 mRNA in human T-lymphocytes. J. Nutr. 1997, 127:257-262.
107. Hopkins R.G., Failla M.L. Transcriptional regulation of the interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymphocytes. J. Nutr. 1999, 129:596-601.
108. Hsu M.H., Palmer C.N., Song W., Griffin K.J., Johnson E.F. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J. Biol. Chem. 1998, 273:27988-27997.
109. Huesca M., Lock L.S., Khine A.A., Viau S., Peralta R., Cukier I.H., Jin H., Al-Qawasmeh R.A., Lee Y., Wright J., Young A. A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis. Mol. Cancer. Ther. 2009, 8:2586-2596.
110. Ioannou G.N., Spector J., Scott K., Rockey D.C. Prospective evaluation of a clinical guideline for the diagnosis and management of iron deficiency anemia. Am. J. Med. 2002, 113:281-287.
111. Iolascon A., d'Apolito M., Servedio V., Cimmino F., Piga A., Camaschella C. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 2006, 107:349-354.
112. Italian Multicentric Study on Centenarians (IMSC) Laboratory parameters of Italian centenarians. Arch. Gerontol. Geriatr. 1998, 27:67-74.
113. Izaks G.J., Westendorp R.G., Knook D.L. The definition of anemia in older persons. JAMA 1999, 281:1714-1717.
114. Jamieson S.E., White J.K., Howsona J.M.M., Paska R., Smith A.N., Brayned C., Evans J.G., Xuer J., Cairns N.J., Rubinsztein D.C., Blackwell J.M. Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease. Neurosci. Lett. 2005, 374:124-128.
115. Jiang Y., Reynolds C., Xiao C., Feng W., Zhou Z., Rodriguez W., Tyagi S.C., Eaton J.W., Saari J.T., Kang Y.J. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J. Exp. Med. 2007, 204:657-666.
116. Johnson M.A., Fischer J.G., Bowman B.A., Gunter E.W. Iron nutriture in elderly individuals. FASEB J. 1994, 8:609-621.
117. Joosten E. Strategies for the laboratory diagnosis of some common causes of anaemia in elderly patients. Gerontology 2004, 50:49-56.
118. Kakhlon O., Breuer W., Munnich A., Cabantchik Z.I. Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation. Can. J. Physiol. Pharmacol. 2010, 88:187-196.
119. Kant A.K. Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 2000, 72:929-936.
120. Kelner G.S., Lee M., Clark M.E., Maciejewski D., McGrath D., Rabizadeh S., Lyons T., Bredesen D., Jenner P., Maki R.A. The copper transport protein Atox1 promotes neuronal survival. J. Biol. Chem. 2000, 275:580-584.
121. Kim C.H., Park J.Y., Kim J.Y., Choi C.S., Kim Y.I., Chung Y.E., Lee M.S., Hong S.K., Lee K.U. Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism 2002, 51:838-842.
122. Kirchman P.A., Botta G. Copper supplementation increases yeast life span under conditions requiring respiratory metabolism. Mech. Ageing Dev. 2007, 128:187-195.
123. Klevay L.M. Cardiovascular disease from copper deficiency: a history. J. Nutr. 2000, 130(2S Suppl):489S-492S.
124. Klipstein-Grobusch K., Grobbee D.E., Koster J.F., Lindemans J., Boeing H., Hofman A., Witteman J.C. Serum caeruloplasmin as a coronary risk factor in the elderly: the Rotterdam Study. Br. J. Nutr. 1999, 81:139-144.
125. Klug A. Zinc finger peptides for the regulation of gene expression. J. Mol. Biol. 1999, 293:215-218.
126. Kobayashi K., Katsuya Y., Abdulah R., Fujisawa C., Nagamine T., Morikawa A., Murakami M., Kodama H., Koyama H. Direct analysis of ceruloplasmin in human blood serum by HPLC/inductively coupled plasma-mass spectrometry for the diagnosis of wilson disease. Biomed. Res. Trace Elem. 2007, 18:91-95.
127. Koller L.D., Mulhern S.A., Frankel N.C., Steven M.G., Williams J.R. Immune dysfunction in rats fed a diet deficient in copper. Am. J. Clin. Nutr. 1987, 45:997-1006.
128. Krajacic P., Qian Y., Hahn P., Dentchev T., Lukinova N., Dunaief J.L. Retinal localization and copper-dependent relocalization of the Wilson and Menkes disease proteins. Invest. Ophthalmol. Vis. Sci. 2006, 47:3129-3134.
129. Kreuder J., Otten A., Fuder H., Tümer Z., Tønnesen T., Horn N., Dralle D. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease. Eur. J. Pediatr. 1993, 152:828-832.
130. Kunzmann A., Dedoussis G., Jajte J., Malavolta M., Mocchegiani E., Bürkle A. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity. Exp. Gerontol. 2008, 43:409-414.
131. Küry S., Dréno B., Bézieau S., Giraudet S., Kharfi M., Kamoun R., Moisan J.P. Identification of SLC39A4 a gene involved in acrodermatitis enteropathica. Nat. Genet. 2002, 31:239-240.
132. Lannfelt L., Blennow K., Zetterberg H., Batsman S., Ames D., Harrison J., Masters C.L., Targum S., Bush A.I., Murdoch R., Wilson J., Ritchie C.W. PBT2-201-EURO study group Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008, 7:779-786.
133. Lee P.L., Gelbart T., West C., Halloran C., Felitti V., Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol. Dis. 2001, 27:783-802.
134. Lee J.Y., Kim J.H., Palmiter R.D., Koh J.Y. Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp. Neurol. 2003, 184:337-347.
135. Lee J.Y., Friedman J.E., Angel I., Kozak A., Koh J.Y. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol. Aging 2004, 25:1315-1321.
136. Levenson C.W., Tassabehji N.M. Iron and ageing: an introduction to iron regulatory mechanisms. Ageing Res. Rev. 2004, 3:251-263.
137. 2+-metalloproteases. Eur. J. Biochem. 1996, 238:744-751.
138. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am. J. Clin. Nutr. 1996, 63:797S-811S.
139. Lio D., Balistreri C.R., Colonna-Romano G., Motta M., Franceschi C., Malaguarnera M., Candore G., Caruso C. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population. Genes Immun. 2002, 3:20-24.
140. Liu G., Men P., Perry G., Smith M.A. Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Methods Mol. Biol. 2010, 610:123-144.
141. Llanos R.M., Mercer J.F. The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol. 2002, 21:259-270.
142. Lowe N.M., Lowe N.M., Fraser W.D., Jackson M.J. Is there a potential therapeutic value of copper and zinc for osteoporosis?. Proc. Nutr. Soc. 2002, 61:181-185.
143. Lynch S.R., Finch C.A., Monsen E.R., Cook J.D. Iron status of elderly Americans. Am. J. Clin. Nutr. 1982, 36:1032-1045.
144. Lyons T.J., Nersissian A., Huang H., Yeom H., Nishida C.R., Graden J.A., Gralla E.B., Valentine J.S. The metal binding properties of the zinc site of yeast copper-zinc superoxide dismutase: implications for amyotrophic lateral sclerosis. J. Biol. Inorg. Chem. 2000, 5:189-203.
145. Ma Y.S., Wu S.B., Lee W.Y., Cheng J.S., Wei Y.H. Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. Biochim. Biophys. Acta. 2009, 1790:1021-1029.
146. Madarić A., Ginter E., Kadrabová J. Serum copper zinc and copper/zinc ratio in males: influence of aging. Physiol. Res. 1994, 43:107-111.
147. Mak C.M., Lam C.W. Diagnosis of Wilson's disease: a comprehensive review. Crit. Rev. Clin. Lab. Sci. 2008, 45:263-290.
148. Malavolta M., Cipriano C., Costarelli L., Giacconi R., Tesei S., Muti E., Piacenza F., Pierpaoli S., Larbi A., Pawelec G., Dedoussis G., Herbein G., Monti D., Jajte J., Rink L., Mocchegiani E. Metallothionein downregulation in very old age: a phenomenon associated with cellular senescence?. Rejuv. Res. 2008, 11:455-459.
149. Malavolta M., Giacconi R., Piacenza F., Santarelli L., Cipriano C., Costarelli L., Tesei S., Pierpaoli S., Basso A., Galeazzi R., Lattanzio F., Mocchegiani E. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology 2010, 11:309-319.
150. Malavolta M., Piacenza F., Basso A., Giacconi R., Costarelli L., Pierpaoli S., Mocchegiani E. Speciation of trace elements in human serum by semi-micro anion exchange chromatography coupled with ICP-MS. Anal. Biochem. 2012, 421:16-25.
151. Malavolta M., Piacenza F., Costarelli L., Giacconi R., Muti E., Cipriano C., Tesei S., Spezia S., Mocchegiani E. Combining UHR-SEC-HPLC-ICP-MS with flow cytometry to quantify metallothioneins and to study zinc homeostasis in human PBMC. J. Anal. At. Spectrom. 2007, 22:1193-1198.
152. Mao X., Schimmer A.D. The toxicology of clioquinol. Toxicol. Lett. 2008, 182:1-6.
153. Marcellini F., Giuli C., Papa R., Gagliardi C., Dedoussis G., Monti D., Jajte J., Giacconi R., Malavolta M., Mocchegiani E. Zinc in elderly people: effects of zinc supplementation on psychological dimensions in dependence of IL-6-174 polymorphism: a Zincage study. Rejuv. Res. 2008, 11:479-483.
154. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signal 2006, 8:1419-1441.
155. Maret W., Jacob C., Vallee B.L., Fischer E.H. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:1936-1940.
156. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 2006, 20:3-18.
157. Mariani E., Cattini L., Neri S., Malavolta M., Mocchegiani E., Ravaglia G., Facchini A. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology 2006, 7:449-459.
158. Mariani E., Mangialasche F., Feliziani F.T., Cecchetti R., Malavolta M., Bastiani P., Baglioni M., Dedoussis G., Fulop T., Herbein G., Jajte J., Monti D., Rink L., Mocchegiani E., Mecocci P. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp. Gerontol. 2008, 43:445-451.
159. Mariani E., Neri S., Cattini L., Mocchegiani E., Malavolta M., Dedoussis G.V., Kanoni S., Rink L., Jajte J., Facchini A. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and -174 IL-6 polymorphic alleles. Exp. Gerontol. 2008, 43:462-471.
160. Martin J.E., Sheaff M.T. Renal ageing. J. Pathol. 2007, 211:198-205.
161. Martin W.R., Ye F.Q., Allen P.S. Increasing striatal iron content associated with normal aging. Mov. Disord. 1998, 13:281-286.
162. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., Mocchegiani E. Differential effects of in vitro zinc treatment on gene expression in peripheral blood mononuclear cells derived from young and elderly individuals. Rejuv. Res. 2007, 10:603-620.
163. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., Mocchegiani E. Effects of interleukin-6-174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp. Gerontol. 2008, 43:423-432.
164. McKie A.T., Latunde-Dada G.O., Miret S., McGregor J.A., Anderson G.J., Vulpe C.D., Wrigglesworth J.M., Simpson R.J. Molecular evidence for the role of a ferric reductase in iron transport. Biochem. Soc. Trans. 2002, 30:722-724.
165. Mercer J.F. The molecular basis of copper-transport diseases. Trends Mol. Med. 2001, 7:64-69.
166. Mestek O., Kominkova J., Koplik R., Kodicek M., Zima T. Quantification of trace elements in human serum fractions by liquid chromatography and inductively coupled plasma mass spectrometry. Appl. Organometal. Chem. 2007, 21:5-14.
167. Meyer K., Jia Y., Cao W.Q., Kashireddy P., Rao M.S. Expression of peroxisome proliferator-activated receptor alpha and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice. Int. J. Oncol. 2002, 21:1175-1180.
168. Milanino R., Frigo A., Bambara L.M., Marrella M., Moretti U., Pasqualicchio M., Biasi D., Gasperini R., Mainenti L., Velo G.P. Copper and zinc status in rheumatoid arthritis: studies of plasma erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin. Exp. Rheumatol. 1993, 11:271-281.
169. Milman N., Ingerslev J., Graudal N. Serum ferritin and iron status in a population of 'healthy' 85-year-old individuals. Scand. J. Clin. Lab. Invest. 1990, 50:77-83.
170. Milne D.B. Copper intake and assessment of copper status. Am. J. Clin. Nutr. 1998, 67:1041S-1045S.
171. Minqin R., Rajendran R., Pan N., Tan B.K., Ong W.Y., Watt F., Halliwell B. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic. Biol. Med. 2005, 38:1206-1211.
172. Miura K., Giskes K., Turrell G. Socio-economic differences in takeaway food consumption among adults. Public Health. Nutr. 2011, 11:1-9.
173. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and betaamyloid peptides. Nat. Genet. 1996, 14:55-61.
174. Mocchegiani E., Bürkle A., Fulop T. Zinc and ageing (ZINCAGE Project). Exp. Gerontol. 2008, 43:361-362.
175. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Tesei S., Malavolta M. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech. Ageing Dev. 2006, 127:517-525.
176. Mocchegiani E., Giacconi R., Cipriano C., Costarelli L., Muti E., Tesei S., Giuli C., Papa R., Marcellini F., Mariani E., Rink L., Herbein G., Varin A., Fulop T., Monti D., Jajte J., Dedoussis G., Gonos E.S., Trougakos I.P., Malavolta M. Zinc metallothioneins, and longevity - effect of zinc supplementation: zincage study. Ann. N. Y.Acad. Sci. 2007, 1119:129-146.
177. Mocchegiani E., Giacconi R., Costarelli L., Muti E., Cipriano C., Tesei S., Pierpaoli S., Giuli C., Papa R., Marcellini F., Gasparini N., Pierandrei R., Piacenza F., Mariani E., Monti D., Dedoussis G., Kanoni S., Herbein G., Fulop T., Rink L., Jajte J., Malavolta M. Zinc deficiency and IL-6-174G/C polymorphism in old people from different European countries: effect of zinc supplementation. Zincage study. Exp. Gerontol. 2008, 43:433-444.
178. Mocchegiani E., Malavolta M. Zinc-gene interaction related to inflammatory/immune response in ageing. Genes Nutr. 2008, 3:61-75.
179. Mocchegiani, E., Malavolta, M., Lattanzio, F., Piacenza, F., Basso, A., Abbatecola, A.M., Russo, A., Giovannini, S., Capoluongo, E., Bustacchini, S., Guffanti, E.E., Bernabei, R., Landi, F., 2011. Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study). Age (Dordr). May 5. doi:10.1007/s11357-011-9252-2.
180. Mocchegiani E., Malavolta M., Muti E., Costarelli L., Cipriano C., Piacenza F., Tesei S., Giacconi R., Lattanzio F. Zinc metallothioneins and longevity: interrelationships with niacin and selenium. Curr. Pharm. Des. 2008, 14:2719-2732.
181. Mocchegiani E., Muzzioli M., Cipriano C., Giacconi R. Zinc T-cell pathways, aging: role of metallothioneins. Mech. Ageing Dev. 1998, 106:183-204.
182. Mocchegiani E., Muzzioli M., Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol. Sci. 2000, 21:205-208.
183. Mocchegiani, E., Romeo, J., Malavolta, M., Costarelli, L., Giacconi, R., Diaz, L.E., Marcos, A., 2012. Zinc: dietary intake and impact of supplementation on immune function in elderly. Age (Dordr). 2012 Jan 6. doi:10.1007/s11357-011-9377-3.
184. Moore T.W., Mayne C.G., Katzenellenbogen J.A. Minireview not picking pockets: nuclear receptor alternate-site modulators (NRAMs). Mol. Endocrinol. 2010, 24:683-695.
185. Moroni F., Di Paolo M.L., Rigo A., Cipriano C., Giacconi R., Recchioni R., Marcheselli F., Malavolta M., Mocchegiani E. Interrelationship among neutrophil efficiency, inflammation, antioxidant activity and zinc pool in very old age. Biogerontology 2005, 6:271-281.
186. Mukhopadhyay C.K., Mazumder B., Lindley P.F., Fox P.L. Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:11546-11551.
187. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 1996, 271:1406-1409.
188. Muñiz C.S., Marchante-Gayón J.M., García Alonso J., Sanz-Medel A. Speciation of essential elements in human serum using anion exchange chromatography coupled to post-column isotope dilution analysis with double focusing ICP-MS. J. Anal. At. Spectrom. 2001, 16:587-592.
189. Munoz C., Rios E., Olivos J., Brunser O., Olivares M. Iron, copper and immunocompetence. Br. J. Nutr 2007, 98(Suppl. 1):S24-S28.
190. National Health and Nutrition Examination Survey, 2007. Anthropometric reference data, United States. 1988-1994. http://www.cdc.gov/nchs/about/major/nhanes/Anthropometric%20Measures.
191. Necela, B.M., Cidlowski, J.A., 2004. A single amino acid change in the first zinc finger of the DNA binding domain of the glucocorticoid receptor regulates differential promoter selectivity. J. Biol. Chem. 279, 39279-39288.
192. Nicolas M.G., Fujiki K., Murayama K., Suzuki M.T., Shindo N., Hotta Y., Iwata F., Fujimura T., Yoshikawa Y., Cho F., Kanai A. Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Exp. Eye Res. 1996, 62:399-408.
193. Nischwitz V., Berthele A., Michalke B. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: an approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal. Chim. Acta. 2008, 627:258-269.
194. Olivares M., Uauy R. Copper as an essential nutrient. Am. J. Clin. Nutr. 1996, 63:791S-796S.
195. Osaki S., Johnson D.A. Mobilization of liver iron by ferroxidase (ceruloplasmin). J. Biol. Chem. 1969, 244:5757-5758.
196. Ostan R., Alberti S., Bucci L., Salvioli S., Pasi S., Cevenini E., Capri M., Di Iorio A., Ginaldi L., De Martinis M., Franceschi C., Monti D. Effect of zinc ions on apoptosis in PBMCs from healthy aged subjects. Biogerontology. 2006, 7:437-447.
197. Owen L.M., Rauscher A.M., Fairweather-Tait S.J., Crews H.M. Use of HPLC with inductively coupled plasma mass spectrometry (ICP-MS) for trace element speciation studies in biological materials. Biochem. Soc. Trans. 1996, 24:947-952.
198. Pagel J.I., Deindl E. Early growth response 1 - a transcription factor in the crossfire of signal transduction cascades. Indian J. Biochem. Biophys. 2011, 48:226-235.
199. Pajonk F.G., Kessler H., Supprian T., Hamzei P., Bach D., Schweickhardt J., Herrmann W., Obeid R., Simons A., Falkai P., Multhaup G., Bayer T.A. Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J. Alzheimers Dis. 2005, 8:23-27.
200. Palmiter R.D. The elusive function of metallothioneins. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8428-8430.
201. Paolisso G., Barbieri M., Bonafè M., Franceschi C. Metabolic age modelling: the lesson from centenarians. Eur. J. Clin. Invest. 2000, 30:888-894.
202. Payne M.A. Zinc finger structure-function in Ikaros. World J. Biol. Chem. 2011, 2:161-166.
203. Pearson R., Fleetwood J., Eaton S., Crossley M., Bao S. Krüppel-like transcription factors: a functional family. Int. J. Biochem. Cell. Biol. 2008, 40:1996-2001.
204. Percival S.S. Neutropenia caused by copper deficiency: possible mechanisms of action. Nutr. Rev. 1995, 53:59-66.
205. Petris M.J., Mercer J.F., Culvenor J.G., Lockhart P., Gleeson P.A., Camakaris J. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J. 1996, 15:6084-6095.
206. Philipsen S., Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999, 27:2991-3000.
207. Phinney A.L., Drisaldi B., Schmidt S.D., Lugowski S., Coronado V., Liang Y., Horne P., Yang J., Sekoulidis J., Coomaraswamy J., Chishti M.A., Cox D.W., Mathews P.M., Nixon R.A., Carlson G.A., St George-Hyslop P., Westaway D. In vivo reduction of amyloid-beta by a mutant copper transporter. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14193-14198.
208. Plum L.M., Rink L., Haase H. The essential toxin: impact of zinc on human health. Int. J. Environ. Res. Public Health 2010, 7:1342-1365.
209. Ponka P., Lok C.N. The transferrin receptor: role in health and disease. Int. J. Biochem. Cell. Biol. 1999, 31:1111-1137.
210. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 2000, 182:S62-S68.
211. Prohaska J.R., Gybina A.A. Intracellular copper transport in mammals. J. Nutr. 2004, 134:1003-1006.
212. Putics A., Vödrös D., Malavolta M., Mocchegiani E., Csermely P., Soti C. Zinc supplementation boosts the stress response in the elderly Hsp70 status is linked to zinc availability in peripheral lymphocytes. Exp. Gerontol. 2008, 43:452-461.
213. Quinn J.F., Crane S., Harris C., Wadsworth T.L. Copper in Alzheimer's disease: too much or too little?. Expert. Rev. Neurother. 2009, 9:631-637.
214. Reddy M.B., Hurrell R.F., Juillerat M.A., Cook J.D. The influence of different protein sources on phytate inhibition of nonheme-iron absorption in humans. Am. J. Clin. Nutr. 1996, 63:203-207.
215. Ridge P.G., Zhang Y., Gladyshev V.N. Comparative genomic analyses of copper transporters and cuproproteomes reveal evolutionary dynamics of copper utilization and its link to oxygen. PLoS ONE 2008, 3:e1378.
216. Rink L., Kirchner H. Zinc-altered immune function and cytokine production. J. Nutr. 2000, 130:1407S-1411S.
217. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R.E., Masters C.L. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 2003, 60:1685-1691.
218. Robson K.J., Lehmann D.J., Wimhurst V.L., Livesey K.J., Combrinck M., Merryweather-Clarke A.T., Warden D.R., Smith A.D. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. J. Med. Genet. 2004, 41:261-265.
219. Rosen G.M., Pou S., Ramos C.L., Cohen M.S., Britigan B.E. Free radicals and phagocytic cells. FASEB J. 1995, 9:200-209.
220. Rossi E., Jeffrey G.P. Clinical penetrance of C282Y homozygous HFE haemochromatosis. Clin. Biochem. Rev. 2004, 25:183-190.
221. Rouault T.A. Post-transcriptional regulation of human iron metabolism by iron regulatory proteins. Blood Cells Mol. Dis. 2002, 29:309-314.
222. Sahyoun N.R., Jacques P.F., Dallal G., Russell R.M. Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. J. Clin. Epidemiol. 1996, 49:981-988.
223. Salonen J.T., Nyyssönen K., Korpela H., Tuomilehto J., Seppänen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992, 86:803-811.
224. Saltman P.D., Strause L.G. The role of trace minerals in osteoporosis. J. Am. Coll. Nutr. 1993, 12:384-389.
225. Sampson E., Jenagaratnam L., McShane R. Metal protein attenuating compounds for the treatment of Alzheimer's disease. Cochrane Database Syst. Rev. 2008, 1:CD005380.
226. Sandstead H.H. Requirements and toxicity of essential trace elements illustrated by zinc and copper. Am. J. Clin. Nutr. 1995, 61:621S-624S.
227. Santos P.C., Falcao R.P. Decreased lymphocyte subsets and NK cell activity in iron deficiency anemia. Acta Hematol. 1990, 84:118-121.
228. Sanz-Medel A., Montes-Bayón M., Luisa Fernández Sánchez M. Trace element speciation by ICP-MS in large biomolecules and its potential for proteomics. Anal. Bioanal. Chem. 2003, 377:236-247.
229. Sensi S.L., Jeng J.M. Re-thinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Curr. Mol. Med. 2004, 4:87-111.
230. Simpson K.M., Morris E.R., Cook J.D. The inhibitory effect of bran on iron absorption in man. Am. J. Clin. Nitr. 1981, 34:1469-1478.
231. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
232. Slagboom P.E., Beekman M., Passtoors W.M., Deelen J., Vaarhorst A.A., Boer J.M., van den Akker E.B., van Heemst D., de Craen A.J., Maier A.B., Rozing M., Mooijaart S.P., Heijmans B.T., Westendorp R.G. Genomics of human longevity. Philos. Trans. R. Soc. Lond. Biol. Sci. 2011, 366:35-42.
233. 2+ release. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13952-13957.
234. Sparks L. Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain. J. Mol. Neurosci. 2004, 24:97-104.
235. Squitti R., Rossini P.M., Cassetta E., Moffa F., Pasqualetti P., Cortesi M., Colloca A., Rossi L., Finazzi-Agró A. d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients. Eur. J. Clin. Invest. 2002, 32:51-59.
236. Stadler N., Lindner R.A., Davies M.J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb. Vasc. Biol. 2004, 24:949-954.
237. Steinberg K.K., Cogswell M.E., Chang J.C., Caudill S.P., McQuillan G.M., Bowman B.A., Grummer-Strawn L.M., Sampson E.J., Khoury M.J., Gallagher M.L. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001, 285:2216-2222.
238. Suzuki K.T., Someya A., Komada Y., Ogra Y. Roles of metallothionein in copper homeostasis: responses to Cu-deficient diets in mice. J. Inorg. Biochem. 2002, 88:173-182.
239. Verstrepen L., Verhelst K., van Loo G., Carpentier I., Ley S.C., Beyaert R. Expression biological activities and mechanisms of action of A20 (TNFAIP3). Biochem. Pharmacol. 2010, 80:2009-2020.
240. Vilborg A., Wilhelm M., Wiman T.K.G. Regulation of tumor suppressor p53 at the RNA level. J. Mol. Med. (Berl). 2010, 88:645-652.
241. Vinayagam, A., Stelzl, U., Foulle, R., Plassmann, S., Zenkner, M., Timm, J., Assmus, H.E., Andrade-Navarro, M.A., Wanker, E.E., 2011 A directed protein interaction network for investigating intracellular signal transduction. Sci. Signal. 4, rs8. doi:10.1126/scisignal.2001699.
242. Swamynathan S.K. Krüppel-like factors: three fingers in control. Hum. Genom. 2010, 4:263-270.
243. Tanaka T., Roy C.N., Yao W., Matteini A., Semba R.D., Arking D., Walston J.D., Fried L.P., Singleton A., Guralnik J., Abecasis G.R., Bandinelli S., Longo D.L., Ferrucci L. Agenome-wide association analysis of serum iron concentrations. Blood 2010, 115:94-96.
244. Tapia L., González-Agüero M., Cisternas M.F., Suazo M., Cambiazo V., Uauy R., González M. Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. Biochem. J. 2004, 378:617-624.
245. tom Dieck H., Döring F., Roth H.P., Daniel H. Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J. Nutr. 2003, 133:1004-1010.
246. Tsaih S.W., Pezzolesi M.G., Yuan R., Warram J.H., Krolewski A.S., Korstanje R. Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. Kidney Int. 2010, 77:201-210.
247. Tuntawiroon M., Sritongkul N., Brune M., Rossander-Hultén L., Pleehachinda R., Suwanik R., Hallberg L. Dose-dependent inhibitory effect of phenolic compounds in foods on nonheme-iron absorption in men. Am. J. Clin. Nutr. 1991, 53:554-557.
248. Tuomainen T.P., Kontula K., Nyyssönen K., Lakka T.A., Heliö T., Salonen J.T. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 1999, 100:1274-1279.
249. Turnlund J.R., Keyes W.R., Kim S.K., Domek J.M. Long-term high copper intake: effects on copper absorption, retention, and homeostasis in men. Am. J. Clin. Nutr. 2005, 81:822-828.
250. Uciechowski P., Kahmann L., Plümäkers B., Malavolta M., Mocchegiani E., Dedoussis G., Herbein G., Jajte J., Fulop T., Rink L. TH1 and TH2 cell polarization increases with aging and is modulated by zinc supplementation. Exp. Gerontol. 2008, 43:493-498.
251. Ugarte M., Osborne N.N. Zinc in the retina. Prog. Neurobiol. 2001, 64:219-249.
252. Umbreit J. Iron deficiency: a concise review. Am. J. Hematol. 2005, 78:225-231.
253. Underwood E.J. Trace metals in human and animal health. J. Hum. Nutr. 1981, 35:37-48.
254. Vandewalle C., Van Roy F., Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol. Life Sci. 2009, 66:773-787.
255. Varin A., Larbi A., Dedoussis G.V., Kanoni S., Jajte J., Rink L., Monti D., Malavolta M., Marcellini F., Mocchegiani E., Herbein G., Fulop T. In vitro and in vivo effects of zinc on cytokine signalling in human T cells. Exp. Gerontol. 2008, 43:472-482.
256. Vasto S., Mocchegiani E., Candore G., Listì F., Colonna-Romano G., Lio D., Malavolta M., Giacconi R., Cipriano C., Caruso C. Inflammation, genes and zinc in ageing and age-related diseases. Biogerontology 2006, 7:315-327.
257. Visser M., Kritchevsky S.B., Newman A.B., Goodpaster B.H., Tylavsky F.A., Nevitt M.C., Harris T.B. Lower serum albumin concentration and change in muscle mass: the health, aging and body composition study. Am. J. Clin. Nutr. 2005, 82:531-537.
258. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochem. J. 2011, 434:365-381.
259. Wang L., Johnson E.E., Shi H.N., Walker W.A., Wessling-Resnick M., Cherayil B.J. Attenuated inflammatory responses hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J. Immunol. 2008, 181:2723-2731.
260. Wang P., Guliaev A.B., Hang B. Metal inhibition of human N-methylpurine-DNA glycosylase activity in base excision repair. Toxicol. Lett. 2006, 166:237-247.
261. Wapnir R.A. Copper absorption and bioavailability. Am. J. Clin. Nutr. 1998, 67:1054S-1060S.
262. Webb M., Holt D. Endogenous metal binding proteins in relation to the differences in absorption and distribution of mercury in newborn and adult rats. Arch. Toxicol. 1982, 49:237-245.
263. Wieser R. The oncogene and developmental regulator EVI 1: expression, biochemical properties, and biological functions. Gene 2007, 396:346-357.
264. Weiss J.H., Sensi S.L., Koh J.Y. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol. Sci. 2000, 21:395-401.
265. Welch K.D., Davis T.Z., Van Eden M.E., Aust S.D. Deleterious iron-mediated oxidation of biomolecules. Free Radic. Biol. Med. 2002, 32:577-583.
266. Werner H., Roberts C.T., LeRoith D. The regulation of IGF-I receptor gene expression by positive and negative zinc-finger transcription factors. Adv. Exp. Med. Biol. 1993, 343:91-103.
267. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., Richards R.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 1990, 8:513-518.
268. Witte K.K., Nikitin N.P., Parker A.C., von Haehling S., Volk H.D., Anker S.D., Clark A.L., Cleland J.G. The effect of micronutrient supplementation on qua lity-of-life and left ventricular function in elderly patients with chronic heart failure. Eur. Heart J. 2005, 26:2238-2244.
269. Wong S.H., Shih R.S., Schoene N.W., Lei K.Y. Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells. Am. J. Physiol. Cell. Physiol. 2008, 294:C1342-C1349.
270. Woodman R., Ferrucci L., Guralnik J. Anemia in older adults. Curr. Opin. Hematol. 2005, 12:123-128.
271. Xu Q., Springer L., Merchant J.L., Jiang H. Identification of zinc finger binding protein 89 (ZBP-89) as a transcriptional activator for a major bovine growth hormone receptor promoter. Mol. Cell. Endocrinol. 2006, 251:88-95.
272. Yang S.W., Becker F.F., Chan J.Y. Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation. Environ. Mol. Mutagen. 1996, 28:19-25.
273. Younce C.W., Azfer A., Kolattukudy P.E. MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2009, 284:27620-27628.
274. Zaahl M.G., Robson K.J., Warnich L., Kotze M.J. Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: opposite effect in the presence of -237C→T. Blood Cells Mol. Dis. 2004, 33:45-50.
275. Zacharski L.R., Chow B.K., Howes P.S., Shamayeva G., Baron J.A., Dalman R.L., Malenka D.J., Ozaki C.K., Lavori P.W. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 2007, 297:603-610.
276. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.
277. Zhang W., Xu C., Bian C., Tempel W., Crombet L., MacKenzie F., Min J., Liu Z., Qi C. Crystal structure of the Cys2His2-type zinc finger domain of human DPF2. Biochem. Biophys. Res. Commun. 2011, 413:58-61.
278. Zhang W.J., Wei H., Frei B. The iron chelator desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice. Exp. Biol. Med. 2010, 235:633-641.